| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 07/21/1999 | CN1044249C Matrix metalloprotease inhibitors |
| 07/20/1999 | US5925772 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 07/20/1999 | US5925678 Use of N-acyl derivatives of aminoalcohols in the manufacture of a medicament for practicing neuroprotective action in neuropathological states connected with excitotoxicity |
| 07/20/1999 | US5925664 Method for treating ocular hypertension and glaucoma |
| 07/20/1999 | US5925626 Hyaluronic acid fractions having pharmaceutical activity, and pharmaceutical compositions containing the same |
| 07/20/1999 | US5925539 Human pelota homolog |
| 07/20/1999 | US5925351 Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| 07/15/1999 | WO1999034830A1 Topical ophthalmic preparations containing immunosuppressive agents |
| 07/15/1999 | WO1999034827A1 Activated t-cells and their uses |
| 07/15/1999 | WO1999034784A2 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis |
| 07/15/1999 | WO1999034763A2 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis |
| 07/15/1999 | CA2317010A1 Topical ophthalmic preparations containing immunosuppressive agents |
| 07/15/1999 | CA2245909A1 Novel compounds |
| 07/14/1999 | EP0928792A2 Bicyclic(3.1.0)hexanes and related compounds |
| 07/14/1999 | EP0928291A1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
| 07/14/1999 | EP0928203A1 Gene therapy for inhibition of angiogenesis |
| 07/14/1999 | EP0928194A1 Compositions and methods for administering integrin receptor antagonists |
| 07/14/1999 | EP0804179B1 Use of n-acyl derivatives of aminoalcohols in the manufacture of a medicament for practising neuroprotective action in neuropathological states connected with excitotoxicity |
| 07/14/1999 | CN1222850A Therapeutic treatment for VEGF related occular diseases |
| 07/13/1999 | US5922875 Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use |
| 07/13/1999 | US5922853 Human pelota homolog |
| 07/13/1999 | US5922773 Treatment with n-methyl-d-aspartate antagonist for vision defects |
| 07/13/1999 | US5922761 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 07/13/1999 | US5922746 Inhibition of noninactivating Na channels of mammalian optic nerve as a means of preventing optic nerve degeneration associated with glaucoma |
| 07/13/1999 | US5922740 Antiinflammatory agents |
| 07/13/1999 | US5922701 Method for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue |
| 07/13/1999 | US5922319 Methods of treating eye conditions with human leukocyte elastase (HLE) inhibitory agents |
| 07/08/1999 | WO1999033827A1 Novel imidazole derivatives |
| 07/08/1999 | WO1999033472A1 Use of surface active agent for the manufacture of a medicament for treatment of disorders of the middle ear |
| 07/08/1999 | WO1999033363A1 Bilberry-containing drinks and process for producing the same |
| 07/08/1999 | WO1999011275A9 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation |
| 07/08/1999 | WO1999009955A3 Lipid-containing compositions and uses thereof |
| 07/07/1999 | EP0927763A2 Novel aroA |
| 07/07/1999 | EP0927191A2 Anti-inflammatory peptides and uses thereof |
| 07/07/1999 | EP0927190A1 Central nervous system-derived immune privilege factor and uses thereof |
| 07/07/1999 | EP0927183A1 Spirocyclic metalloprotease inhibitors |
| 07/07/1999 | EP0927177A1 Novel benzothiophene derivatives, their preparation and use as urokinase inhibitors |
| 07/07/1999 | EP0927170A1 Piperazino derivatives as neurokinin antagonists |
| 07/07/1999 | EP0927168A1 1,3-diheterocyclic metalloprotease inhibitors |
| 07/07/1999 | EP0927161A1 Substituted cyclic amine metalloprotease inhibitors |
| 07/07/1999 | EP0927156A1 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
| 07/07/1999 | EP0927031A1 Pharmaceutical preparation containing nimesulide for oral administration |
| 07/07/1999 | EP0927024A2 Device and method for treating ophthalmic diseases |
| 07/07/1999 | EP0701438B1 Gaba-ergic modulation of eye growth |
| 07/07/1999 | EP0500807B1 Tissue moisturizing composition and method |
| 07/06/1999 | US5919943 Inhibition of spla2 |
| 07/06/1999 | US5919904 Response regulator polypeptides; screening for bactericides |
| 07/06/1999 | US5919810 1H-indole-3-glyoxylamide sPLA2 inhibitors |
| 07/06/1999 | US5919805 Hetrocyclic compounds and their preparation and use |
| 07/06/1999 | US5919789 Xanthines and their therapeutic use |
| 07/06/1999 | US5919774 Novel compounds such as 2-(1-benzyl-2,5-dimethyl-4-(2-carboxyphenylmethyl)pyrrol-3-yl) glyoxamide for inhibiting human nonpancreatic secretory phospholipase a2 (spla2) mediated release of fatty acids in a mammal |
| 07/06/1999 | US5919664 For screening for antibacterial compounds |
| 07/01/1999 | WO1999032456A1 Phthalazine derivatives phosphodiesterase 4 inhibitors |
| 07/01/1999 | WO1999032452A1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
| 07/01/1999 | WO1999032451A1 Azepine or larger medium ring derivatives and their use as pharmaceuticals |
| 07/01/1999 | WO1999032158A2 Aminobiguanides to disinfect contact lenses and preserve pharmaceutical compositions |
| 07/01/1999 | WO1999032127A1 Angiostatic agents and compositions for controlling ocular hypertension |
| 07/01/1999 | WO1999032125A1 Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
| 07/01/1999 | WO1999032123A1 The use of brinzolamide to prevent visual field loss |
| 07/01/1999 | WO1999032104A1 Use of 3-benzoyl-phenylacetic acids, esters, or amides for treatment of glc1a glaucoma |
| 07/01/1999 | WO1999032101A1 Treatment of glc1a glaucoma with non-steroidal glucocorticoid antagonists |
| 07/01/1999 | WO1999032087A1 Water-soluble eye drop |
| 07/01/1999 | WO1999024051A3 Application of vasopressin antagonists for treating disturbances or illnesses of the inner ear |
| 07/01/1999 | WO1999003817B1 Aliphatic propargylamines as cellular rescue agents |
| 07/01/1999 | CA2313386A1 Use of 3-benzoyl-phenylacetic acids, esters, or amides for treatment of glc1a glaucoma |
| 07/01/1999 | CA2313232A1 Treatment of glc1a glaucoma with non-steroidal glucocorticoid antagonists |
| 06/30/1999 | EP0925789A1 Topical azithromycin compositions for the treatment of ocular infections |
| 06/30/1999 | EP0925303A1 Phosphinic acid amides as matrix metalloprotease inhibitors |
| 06/30/1999 | EP0925287A1 Heterocyclic metalloprotease inhibitors |
| 06/30/1999 | EP0925071A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions |
| 06/29/1999 | US5916887 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 06/29/1999 | CA2255202A1 Use of flavin adenine dinucleotide in the preparation of ophthalmic formulations for the treatment of dry eye |
| 06/24/1999 | WO1999031105A1 3-substituted adenines via2-thioxanthines |
| 06/24/1999 | WO1999031104A1 Preparation of 3-substituted adenines and imidazo pyridines |
| 06/24/1999 | WO1999031103A1 Preparation of 3-substituted adenines |
| 06/24/1999 | WO1999031102A1 Purine derivatives having phosphodiesterase iv inhibition activity |
| 06/24/1999 | WO1999031099A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999031088A1 Triazine angiogenesis inhibitors |
| 06/24/1999 | WO1999031061A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999030713A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999030709A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999030703A1 Use of formoterol in medicament for inflammation/allergy in upper airways |
| 06/24/1999 | WO1999005155A3 Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof |
| 06/24/1999 | CA2315370A1 Integrin receptor antagonists |
| 06/24/1999 | CA2315232A1 Integrin receptor antagonists |
| 06/24/1999 | CA2314335A1 Purine derivatives having phosphodiesterase iv inhibition activity |
| 06/24/1999 | CA2313776A1 Triazine angiogenesis inhibitors |
| 06/24/1999 | CA2313004A1 3-substituted adenines via2-thioxanthines |
| 06/23/1999 | EP0923567A1 Benzylamine derivatives, their preparation and their application in therapeutics |
| 06/23/1999 | EP0923563A1 1,4-heterocyclic metallprotease inhibitors |
| 06/23/1999 | EP0923561A1 Heterocyclic metalloprotease inhibitors |
| 06/23/1999 | EP0923547A1 Bidentate metalloprotease inhibitors |
| 06/23/1999 | EP0923530A1 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |
| 06/23/1999 | EP0923529A1 Subsitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors |
| 06/23/1999 | CN1220656A Novel trienoic retinoid compounds and method |
| 06/23/1999 | CN1043762C Compound used for excitary amino acid receptor antagonists and its drug composition |
| 06/22/1999 | US5914338 Heterocyclic compounds and their preparation and use |
| 06/19/1999 | CA2256303A1 The use of mmp inhibitors for the treatment of ocular angiogenesis |
| 06/17/1999 | WO1999029878A2 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
| 06/17/1999 | WO1999029858A1 Soluble inhibitors of vascular endothelial growth factor and use thereof |